Timothy Johnson

Timothy Johnson is an experienced oncology sales professional with a strong background in pharmaceutical marketing and customer relationship management. Currently serving as the Oncology Disease Area Lead at Novartis since July 2024, Timothy also holds the position of Senior Clinical Sales Specialist/RAM at Helsinn Group, focusing on promoting Akynzeo to medical oncologists. Previous positions include Senior Executive Sales Representative at Eli Lilly and Company, where Timothy launched Verzenio for breast cancer, and Regional Oncogenomic Liaison at Genomic Health, responsible for marketing Oncotypedx assays for cancer treatment recommendations. Timothy's career also includes roles at Allos Therapeutics, Eli Lilly, ImClone Systems, Abraxis Oncology, and Ligand Pharmaceuticals, consistently demonstrating expertise in driving product sales and establishing key client relationships across various oncology products. Timothy holds a Bachelor of Arts Degree in Management from Saint Leo University.